Influenza Vaccine Market & Forecast in West Europe 2017 - Rising Healthcare Expenditure Share of the Western Europe Countries GDP - Research and Markets

News provided by

Research and Markets

11 May, 2017, 17:45 BST

DUBLIN, May 11, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Influenza Vaccine Market & Forecast in (West Europe) Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom By (Child & Adult)" report to their offering.

Influenza vaccine market for West Europe was more than US$ 500 Million. United Kingdom is having the highest seasonal influenza vaccine market share followed by Germany and France respectively. In children vaccination, United Kingdom is the leader and France holds the second spot. In adult vaccination United Kingdom and Germany have a close fight for top slot.

Influenza Vaccine Market & Forecast in (West Europe) Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom By (Child & Adult) is a 113 page report with 99 Figures and 11 Tables covers 7 countries of Europe countries influenza vaccine market. In total 7 Europe Countries influenza vaccine market and its vaccinated population numbers have been captured in the report. All the 7 Europe countries are as follows: Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom.


Key Questions Answered in the Report?

  • What is the Influenza Vaccine Market in Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom?
  • What is the Children Influenza Vaccine Market in Poland, Germany, Netherlands, France, Luxembourg, Ireland, and United Kingdom?
  • What is the Adult Influenza Vaccine Market in United Kingdom, France, Luxembourg, Ireland, Germany, Poland and Netherlands?
  • What is the Influenza Vaccinated Population & Forecast in Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom?
  • What is the Influenza Vaccinated Population & Forecast for Children in Poland, Germany, Netherlands, France, Luxembourg, Ireland, and United Kingdom?
  • What is the Influenza Vaccinated Population & Forecast for Adult in United Kingdom, France, Luxembourg, Ireland, Germany, Poland and Netherlands?

Growth Drivers:

  • Vaccine Manufacturers Plan to Increase Flu Vaccine Production
  • Growing Child & Ageing Population in Western European Region
  • Rising Healthcare Expenditure Share of the Western Europe Countries GDP

Market Challenges:

  • Regulatory Challenges with New and Novel Influenza Vaccines
  • Lack of Healthcare Infrastructure
  • Limited Reimbursement and Access to the Vaccines

Key Topics Covered:

1 Executive Summary

2 Western Europe Countries Seasonal Influenza Vaccinated Total Population

3 Western Europe Countries Seasonal Influenza Vaccine Market

4 Western Europe Countries Seasonal Influenza Vaccine Market Share

5 Netherlands

6 Germany

7 France

8 Ireland

9 Luxembourg

10 Poland

11 United Kingdom

12 Seasonal Influenza Vaccine - Growth Drivers

13 Seasonal Influenza Vaccine - Challenges

For more information about this report visit http://www.researchandmarkets.com/research/lp9s79/influenza_vaccine

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets